Biotech grants
Explore grants for biotech companies. This directory brings together funding for therapeutics, diagnostics, platform technologies, bioprocessing and translational research, from health research agencies, national innovation programs, disease foundations and industry partnerships.
Showing 361-384 of 2,745 grants
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
🇺🇸MRDC / CDMRP · United States
Funds an unsolicited medical research idea across USAMRDC's whole portfolio, but only after a pre-proposal through eBRAP earns an invitation to submit in full.
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders
🇺🇸NIH · United States
Funds IND-enabling studies and planning that take a gene-based therapy for an ultra-rare neurological or neuromuscular disorder toward its first human trial.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
Early-Stage Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds early-stage development of new cancer-research software tools, from first prototype to their first real users.
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award
🇺🇸NIH · United States
Funds collaborative projects that build, test and spread new tools or methods across NIH's national network of clinical and translational research hubs.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery
NIH · United States
Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification
NIH · United States
Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies
NIH · United States
Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01)
🇺🇸NIH · United States
Funds one investigator's discovery-to-proof-of-concept project on a new drug, ligand or neurostimulation device for a mental or substance use disorder.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19)
🇺🇸NIH · United States
Funds a coordinated multi-project program discovering and testing new drugs, ligands or neurostimulation devices for mental or substance use disorders.
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards
🇺🇸NIH · United States
Funds the renewal of a neurology clinical trial the institute already supports, where finishing it needs more time and resources.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
Toward Translation of Nanotechnology Cancer Interventions (TTNCI)
🇺🇸NIH · United States
Funds advanced preclinical work maturing a nanoparticle-based cancer diagnostic or therapeutic toward the National Cancer Institute's own translation pipeline.
Basic Research in Cancer Health Disparities (R21)
NIH · United States
Funds early-stage mechanistic work on the biological and genetic causes of cancer health disparities, on a shorter and smaller footing.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases
🇺🇸NIH · United States
Funds basic biochemical or biological work on a protein from a published list — druggable, linked to a rare disease, and barely studied.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK
🇺🇸NIH · United States
Funds pilot basic and translational work on HIV complications in the organs and processes the diabetes, digestive and kidney institute covers.
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
🇺🇸NIH · United States
Funds basic research on the harm caused by a single exposure to ultra-potent synthetic opioids, including the effects that appear later.
ARO Core BAA — Single Investigator
🇺🇸ARO · United States
Offers core basic research grants across physical, engineering, and information science domains in the Army.